Validation of myeloproliferative neoplasms associated risk factor RDW as predictor of thromboembolic complications in healthy individuals: analysis on 6849 participants of the SHIP-study.
Kirsi Marjaana ManzJeanette BahrTill IttermannKonstanze DöhnerSteffen KoschmiederTim H BrümmendorfMartin GriesshammerMatthias NauckHenry VölzkeFlorian H HeidelPublished in: Leukemia (2023)
Keyphrases